Morgan Stanley raised the firm’s price target on American Healthcare REIT (AHR) to $29 from $27 and keeps an Overweight rating on the shares after updating estimates to reflect Q3 earnings and mark to market the multiple based on where healthcare peers have traded.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $30 from $28 at RBC Capital
- American Healthcare REIT price target raised to $36 from $31 at BofA
- American Healthcare REIT price target raised to $29 from $27 at Truist
- American Healthcare REIT, Inc. Reports Q3 2024 Results